Medicxi Ventures Management (jersey) Ltd

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001715579
Type: FundHoldings: 5Value: $437.7MLatest: 2025Q1

Medicxi Ventures Management (Jersey) Ltd is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 5 holdings worth $0.4 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-11
Total Holdings
5
Total Value
437696267
Accession Number
0000950123-25-003449
Form Type
13F-HR
Manager Name
Medicxi-Ventures-Management-Jersey
Data Enrichment
100% identified
5 identified0 unidentified

Holdings

5 positions • $437.7M total value
Manager:
Search and click to pin securities to the top
Centessa Pharmaceuticals plc
Shares:20.0M
Value:$287.1M
% of Portfolio:65.6% ($287.1M/$437.7M)
NewAmsterdam Pharma Co N.V.
Shares:2.9M
Value:$58.7M
% of Portfolio:13.4% ($58.7M/$437.7M)
Phathom Pharmaceuticals, Inc.
Shares:7.5M
Value:$46.8M
% of Portfolio:10.7% ($46.8M/$437.7M)
RAPT Therapeutics, Inc.
Shares:22.4M
Value:$27.3M
% of Portfolio:6.2% ($27.3M/$437.7M)
Aura Biosciences, Inc.
Shares:3.0M
Value:$17.8M
% of Portfolio:4.1% ($17.8M/$437.7M)